Clinical trials
Observational Nervous System Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospices Civils de Lyon | 3 |
| Imagine Institute | 3 |
| University Hospital, Clermont-Ferrand | 2 |
| University Hospital, Toulouse | 2 |
| Azafaros B.V. | 1 |
| CHU de Reims | 1 |
| EMD Serono | 1 |
| GenSight Biologics | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 25 |
| Genetic Diseases, Inborn | 6 |
| Autoimmune Diseases | 4 |
| Central Nervous System Diseases | 3 |
| Immune System Diseases | 3 |
| Autoimmune Diseases of the Nervous System | 2 |
| Brain Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Demyelinating Diseases | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.